Advancing connected cardiometabolic care across the full patient journey
IMPACT-MED brings together leading clinical, research, industry and patient organisation partners to develop and validate a new model of multidisciplinary cardio-metabolic care, combining digital innovation, real-world evidence and personalised care pathways.
A flagship 
European
Health Innovation Initiative JU
Supported by the Innovative Health Initiative Joint Undertaking (IHI JU), IMPACT-MED brings together 26 partners across 13 countries to accelerate the transformation of cardiometabolic care in Europe.
Rethinking cardiometabolic care
The Challenge
Cardiometabolic diseases — including hypertension, diabetes, obesity and cardiovascular conditions — represent a major and growing burden for healthcare systems across Europe.
Patients living with cardiometabolic diseases frequently experience multiple interconnected chronic conditions requiring coordinated care across specialties and healthcare settings.
- Fragmented, with limited coordination across disciplines and care settings.
- Insufficiently personalised, relying on standardised approaches rather than patient-specific needs.
- Reactive, focusing on acute events instead of prevention and early intervention.
- Digitally disconnected, with isolated tools and limited integration of real-world data.
A new model for connected care
IMPACT-MED proposes a paradigm shift towards a more integrated and proactive model of care. At its core is the Multidisciplinary Cardio-Metabolic Care (MCMC) framework, designed to:
- Integrate multiple medical specialties into coordinated care pathways.
- Connect clinical and patient-generated data across settings.
- Enable personalised and continuous care.
- Support patients throughout the full disease trajectory.
This model is supported by an advanced digital ecosystem combining:
- Predictive analytics for earlier risk detection
- Continuous remote monitoring across care settings
- Integration of patient-reported and clinical data
- Personalised decision support tools
- Interoperable digital infrastructures
Clinical use cases
IMPACT-MED will validate its multidisciplinary cardio-metabolic care (MCMC) framework through four real-world clinical studies designed to improve prevention, monitoring, personalised treatment and long-term disease management across the cardiometabolic continuum.
AI-driven hypertension management (UC1)
Improving blood pressure control and enabling earlier detection of cardiovascular complications in high-risk patients through AI-based risk stratification, remote monitoring and digital follow-up tools.
Remote monitoring for cardiovascular (UC2)
Strengthening outpatient follow-up and continuity of care for patients with hypertension and a history of myocardial infarction through remote monitoring and predictive analytics.
Supporting Type 1 diabetes self-management (UC3)
Improving treatment adherence, self-management and quality of care for children, adolescents and young adults living with Type 1 diabetes through personalised digital education and remote monitoring.
Personalised care for Type 2 diabetes (UC4)
Supporting more personalised treatment decisions and improved clinical outcomes for patients living with Type 2 diabetes and obesity through advanced imaging, AI-based risk prediction and patient-reported data.
Expected Impact
IMPACT-MED aims to accelerate the transition towards more proactive, personalised and sustainable cardiometabolic care models across Europe.
Clinical impact
- Earlier risk detection and intervention
- More personalised and continuous care pathways
- Improved disease management across multimorbid conditions
- Reduction of avoidable complications and hospitalisations
Patient impact
- Greater patient engagement and self-management capacity
- Improved continuity of care across the patient journey
- More personalised treatment and monitoring strategies
- Better quality of life and long-term outcomes
HC system impact
- Reduced fragmentation across healthcare settings and specialties
- More scalable and sustainable care models
- Increased adoption of data-driven and value-based healthcare
- Lower long-term burden of cardiometabolic diseases
A collaborative European ecosystem
IMPACT-MED brings together leading healthcare providers, research institutions, industry partners and patient organisations to collaboratively advance a new model of integrated cardiometabolic care.
